Forestier

2021

Publications

• Subcutaneous Antibiotic Therapy: The Why, How, Which Drugs and When

2020

Publications

• Outpatient Subcutaneous Antimicrobial Therapy (OSCAT) as a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections
• Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France

Formation continue et webinaires

• Place des dosages d’antibiotiques dans la PEC des IOA

Cas cliniques

• The Potential Innovative Use of Bacteriophages Within the DAC ® Hydrogel to Treat Patients With Knee Megaprosthesis Infection Requiring « Debridement Antibiotics and Implant Retention » and Soft Tissue Coverage as Salvage Therapy

2019

Publications

• Subcutaneous teicoplanin in staphylococcal bone and joint infections

2018

Posters

• Staphylococcal acute post-operative prosthetic joint infection (PJI) treated with ‘DAIR’ (debridement and implant retention) and impact of rifampin: a retrospective cohort study in France

2017

Publications

• Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study

2016

Posters

• Biofilm : Adaptation in vivo des souches de S. aureus responsables d’IOA

Publications

• Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration

2015

Posters

• Antibiothérapie suppressive (ABS) dans les infections de prothèses ostéo-articulaires (IPOA) chez le patient âgé